Latest News

• Phase III DORA Study Now Enrolling Patients with mCRPC

  Press Releases by PCCTC April 19, 2019

  

  The phase III DORA study (ClinicalTrials.gov Identifier: NCT03574571) led by PCCTC investigator Dr. Michael Morris (Memorial Sloan Kettering Cancer Center) is n...

  Learn More

• Blood Test Predicts Resistance To Hormonal Therapy

  Press Releases by MedPage Today March 18, 2019

  

  AR-V7 successfully predicted resistance to hormonal therapy in advanced prostate cancer...

  Learn More

• Clinical Implications of Genetics in Prostate Cancer

  Press Releases by ASCO Daily News February 18, 2019

  

  PCCTC investigator Dr. Heather Cheng discusses future of cancer care...

  Learn More

• The PCCTC Is Expanding

  Press Releases by admin February 15, 2019

  

  The PCCTC is currently seeking a Quality Manager and Clinical Data Manager to join its team...

  Learn More

• PCCTC Medical Director Discusses Biomarkers in Prostate Cancer

  Press Releases by admin December 18, 2018

  

  Dr. Michael Morris describes the need to be stratified by risk through biomarkers...

  Learn More

• Movember Seeking Clinical Research Project Manager for IRONMAN Re...

  Press Releases by admin October 26, 2018

  

  The PCCTC serves as the the program's Global Clinical and Data Coordination Center. ...

  Learn More